Carcinoid heart disease is the collective term for all cardiac manifestations in patients who
have carcinoid syndrome. Carcinoid heart disease has a multifactorial pathophysiology, and …

Neuroendocrine tumors (NETs) originate from the neuroendocrine cell system in the
bronchial and gastrointestinal tract and can produce hormones leading to distinct clinical …

Objective Carcinoid heart disease is characterized by tricuspid valve regurgitation and
varying degrees of pulmonary valve regurgitation or stenosis. Valve replacement …

Objective: The aim of this study was to determine outcomes of primary tumor resection in
metastatic neuroendocrine tumors across all primary tumor sites. Background: Primary tumor …

Neuroendocrine tumors (NETs) arise from enterochromaffin cells found in neuroendocrine
tissues, with most occurring in the gastrointestinal tract. The global incidence of NETs has …

Neuroendocrine neoplasms arise from the gastrointestinal tract and can lead to carcinoid
syndrome. Carcinoid heart disease affects more than half of these patients and is the initial …

Abstract Purpose of Review Carcinoid heart disease is a rare disorder that is associated with
significant morbidity and mortality. In this review of the literature, we will present current …

Carcinoid heart disease (CHD) is a consequence of valvular fibrosis triggered by vasoactive
substances released from neuroendocrine tumours, classically in those with metastatic …

Aim: Elevated serotonin in patients with neuroendocrine tumors (NETs) may impact heart
failure incidence but a quantitative relationship has not been established. Materials & …

Neuroendocrine paraneoplastic syndromes (PNS) consist of metabolic disorders that
accompany benign and malignant neoplasms but remain unrelated to mass effects or …